Treatment Approaches for Melanomas That Relapse After Adjuvant or Neoadjuvant Therapy

por Ng, Gary, Xu, Wen, Atkinson, Victoria
Publicado 2022

Tumoral melanosis associated with combined BRAF/MEK inhibition (dabrafenib/trametinib) in metastatic melanoma

por Laino, Antonia, Shepherd, Benjamin, Atkinson, Victoria, Fu, Hong, Soyer, H. Peter, Schaider, Helmut
Publicado 2018

Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanoma

por Atkinson, Victoria, Khattak, Adnan, Haydon, Andrew, Eastgate, Melissa, Roy, Amitesh, Prithviraj, Prashanth, Mueller, Christian, Brignone, Chrystelle, Triebel, Frederic
Publicado 2020

Updated efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in metastatic melanoma patients previously treated with anti-PD-1 therapy

por Prithviraj, Prashanth, McArthur, Grant, Atkinson, Victoria, Parente, Phillip, Andrews, Miles, Parakh, Sagun, Millward, Michael, Cebon, Jonathan, Klein, Oliver
Publicado 2015

Dual catalytic enantioselective desymmetrization of allene-tethered cyclohexanones

por Zhang, Lin, Yamazaki, Ken, Leitch, Jamie A., Manzano, Ruben, Atkinson, Victoria A. M., Hamlin, Trevor A., Dixon, Darren J.
Publicado 2020

Histological diagnosis of immune checkpoint inhibitor induced acute renal injury in patients with metastatic melanoma: a retrospective case series report

por Hultin, Sebastian, Nahar, Kazi, Menzies, Alexander M., Long, Georgina V., Fernando, Suran L., Atkinson, Victoria, Cebon, Jonathan, Wong, Muh Geot
Publicado 2020

Protocol for implementation of the ‘AusPROM’ recommendations for elective surgery patients: a mixed-methods cohort study

por Morris, Meg E, Brusco, Natasha, Woods, Jeffrey, Myles, Paul S, Hodge, Anita, Jones, Cathy, Lloyd, Damien, Rovtar, Vincent, Clifford, Amanda, Atkinson, Victoria
Publicado 2021

Implementing PROMS for elective surgery patients: feasibility, response rate, degree of recovery and patient acceptability

por Brusco, Natasha K., Atkinson, Victoria, Woods, Jeffrey, Myles, Paul S., Hodge, Anita, Jones, Cathy, Lloyd, Damien, Rovtar, Vincent, Clifford, Amanda M., Morris, Meg E.
Publicado 2022

In-Depth Characterisation of Real-World Advanced Melanoma Patients Receiving Immunotherapies and/or Targeted Therapies: A Case Series

por Sanjida, Saira, Betz-Stablein, Brigid, Atkinson, Victoria, Janda, Monika, Barsoum, Ramez, Edwards, Harrison Aljian, Chiu, Frank, Tran, My Co, Soyer, H Peter, Schaider, Helmut
Publicado 2022

Patient Judgement of Change with Elective Surgery Correlates with Patient Reported Outcomes and Quality of Life

por Morris, Meg E., Atkinson, Victoria, Woods, Jeffrey, Myles, Paul S., Hodge, Anita, Jones, Cathy H., Lloyd, Damien, Rovtar, Vincent, Clifford, Amanda M., Brusco, Natasha K.
Publicado 2022

Supportive care needs in Australian melanoma patients and caregivers: results from a quantitative cross-sectional survey

por Thompson, Jake R., Fu, Hong, Saw, Robyn P. M., Sherman, Kerry A., Beedle, Victoria, Atkinson, Victoria, Boyle, Frances, O’Sullivan, Niamh A., Martin, Linda K., Bartula, Iris
Publicado 2023

Human CD141(+) dendritic cells (cDC1) are impaired in patients with advanced melanoma but can be targeted to enhance anti-PD-1 in a humanized mouse model

por Lee, Yoke Seng, O'Brien, Liam J, Walpole, Carina M, Pearson, Frances E, Leal-Rojas, Ingrid M, Masterman, Kelly-Anne, Atkinson, Victoria, Barbour, Andrew, Radford, Kristen J
Publicado 2021

Poor Potential Coverage for 7-Valent Pneumococcal Conjugate Vaccine, Malawi

por Gordon, Stephen B., Kanyanda, Stonard, Walsh, Amanda L., Goddard, Kristy, Chaponda, Mas, Atkinson, Victoria, Mulwafu, Wakisa, Molyneux, Elizabeth M., Zijlstra, Ed E., Molyneux, Malcolm E., Graham, Steve M.
Publicado 2003

Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipilimumab in Advanced Melanoma

por Homicsko, Krisztian, Dummer, Reinhard, Hoeller, Christoph, Wolchok, Jedd D., Hodi, F. Stephen, Larkin, James, Ascierto, Paolo A., Atkinson, Victoria, Robert, Caroline, Postow, Michael A., Re, Sandra, Paulucci, David, Dobler, Darin, Michielin, Olivier
Publicado 2022

Stereotactic radiosurgery for melanoma brain metastases: Concurrent immune checkpoint inhibitor therapy associated with superior clinicoradiological response outcomes

por Shanker, Mihir D, Garimall, Sidyarth, Gatt, Nick, Foley, Heath, Crowley, Samuel, Le Cornu, Emma, Muscat, Kendall, Soon, Wei, Atkinson, Victoria, Xu, Wen, Watkins, Trevor, Huo, Michael, Foote, Matthew C, Pinkham, Mark B
Publicado 2022

Case series: Immune checkpoint inhibitor-induced transverse myelitis

por Chatterton, Sophie, Xi, Shuo, Jia, Jessica Xi, Krause, Martin, Long, Georgina V., Atkinson, Victoria, Menzies, Alexander M., Fernando, Suran L., Boyle, Thérèse, Kwok, Samuel, Duggins, Andrew, Karikios, Deme, Parratt, John D. E.
Publicado 2023

Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients

por Aoude, Lauren G., Bonazzi, Vanessa F., Brosda, Sandra, Patel, Kalpana, Koufariotis, Lambros T., Oey, Harald, Nones, Katia, Wood, Scott, Pearson, John V., Lonie, James M., Arneil, Melissa, Atkinson, Victoria, Smithers, B. Mark, Waddell, Nicola, Barbour, Andrew P.
Publicado 2020

coBRIM: a phase 3, double-blind, placebo-controlled study of vemurafenib versus vemurafenib + cobimetinib in previously untreated BRAF(V600) mutation–positive patients with unresec...

por Ascierto, Paolo A, McArthur, Grant A, Dréno, Brigitte, Larkin, James, Liszkay, Gabriella, Maio, Michele, Mandala, Mario, Demidov, Lev, Stroyakovskiy, Daniil, Thomas, Luc, de la Cruz-Merino, Luis, Atkinson, Victoria, Dutriaux, Caroline, Garbe, Claus, Chang, Ilsung, Hack, Stephen P, Ribas, Antoni
Publicado 2015

Efficacy of immune checkpoint inhibitors for in-transit melanoma

por Nan Tie, Emilia, Lai-Kwon, Julia, Rtshiladze, Michael Alexander, Na, Lumine, Bozzi, James, Read, Tavis, Atkinson, Victoria, Au-Yeung, George, Long, Georgina V, McArthur, Grant A, Sandhu, Shahneen, Saw, Robyn, Walpole, Euan, Menzies, Alexander, Smithers, Mark, Gyorki, David E
Publicado 2020

A Retrospective Analysis of Dabrafenib and/or Dabrafenib Plus Trametinib Combination in Patients with Metastatic Melanoma to Characterize Patients with Long-Term Benefit in the Ind...

por Atkinson, Victoria G., Quaglino, Pietro, Aglietta, Massimo, Del Vecchio, Michele, Depenni, Roberta, Consoli, Francesca, Bafaloukos, Dimitrios, Ferrucci, Pier Francesco, Tulyte, Skaiste, Krajsová, Ivana, Ascierto, Paolo A., Gueli, Rossana, Arance, Ana, Gogas, Helen, Banerjee, Hiya, Saliba, Teddy, de Jong, Egbert, Neyns, Bart
Publicado 2021